GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (WBO:MRK) » Definitions » Accumulated other comprehensive income (loss)

Merck (WBO:MRK) Accumulated other comprehensive income (loss) : €-4,852 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Merck Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Merck's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-4,852 Mil.

Merck's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (€-4,606 Mil) to Dec. 2023 (€-4,733 Mil) and declined from Dec. 2023 (€-4,733 Mil) to Mar. 2024 (€-4,852 Mil).

Merck's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-3,920 Mil) to Dec. 2022 (€-4,501 Mil) and declined from Dec. 2022 (€-4,501 Mil) to Dec. 2023 (€-4,733 Mil).


Merck Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Merck's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Accumulated other comprehensive income (loss) Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,573.70 -5,453.15 -3,919.67 -4,500.99 -4,732.64

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,560.72 -4,522.70 -4,606.29 -4,732.64 -4,852.08

Merck Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Merck Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Merck's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (WBO:MRK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (WBO:MRK) » Definitions » Accumulated other comprehensive income (loss)
Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (WBO:MRK) Headlines

From GuruFocus

Merck & Co Inc at UBS BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc To Host ESMO Call (Virtual) Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc at ASCO Annual Meeting Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Investor Event at ACC.23/WCC Transcript

By GuruFocus Research 01-23-2024